Unveiling myocardial microstructure shifts: exploring the impact of diabetes in stable CAD patients through CMR T1 mapping
暂无分享,去创建一个
W. Hueb | E. Lima | Matheus de Oliveira Laterza Ribeiro | J. A. Ramires | C. Rochitte | Cesar Higa Nomura | Gustavo André Boeing Boros | Paulo Cury Rezende | Anderson Roberto Dallazen | R. M. Garcia | Roberto Kalil-Filho
[1] S. Plein,et al. The independent association of myocardial extracellular volume and myocardial blood flow with cardiac diastolic function in patients with type 2 diabetes: a prospective cross-sectional cohort study , 2023, Cardiovascular Diabetology.
[2] S. Blankenberg,et al. Cardiac magnetic resonance feature tracking global and segmental strain in acute and chronic ST-elevation myocardial infarction , 2022, Scientific Reports.
[3] Yue Gao,et al. Cardiac magnetic resonance T1 mapping for evaluating myocardial fibrosis in patients with type 2 diabetes mellitus: correlation with left ventricular longitudinal diastolic dysfunction , 2022, European Radiology.
[4] Lawrence A Leiter,et al. Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease. , 2021, JACC. Cardiovascular imaging.
[5] F. von Knobelsdorff-Brenkenhoff,et al. Quantification of myocardial strain assessed by cardiovascular magnetic resonance feature tracking in healthy subjects—influence of segmentation and analysis software , 2020, European Radiology.
[6] E. Nagel,et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.
[7] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.
[8] Amit R. Patel,et al. Regional myocardial strain by cardiac magnetic resonance feature tracking for detection of scar in ischemic heart disease. , 2020, Magnetic resonance imaging.
[9] Amit R. Patel,et al. Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement , 2019, Journal of Cardiovascular Magnetic Resonance.
[10] W. Rathmann,et al. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population , 2018, European heart journal cardiovascular Imaging.
[11] A. Greiser,et al. Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain , 2018, Cardiovascular Diabetology.
[12] K. Diao,et al. Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis , 2016, Journal of Cardiovascular Magnetic Resonance.
[13] S. Plein,et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.
[14] G. Pedrizzetti,et al. Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use , 2016, Journal of Cardiovascular Magnetic Resonance.
[15] B. Gersh,et al. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial. , 2016, The Annals of thoracic surgery.
[16] Daniel Messroghli,et al. State of the Art: Clinical Applications of Cardiac T1 Mapping. , 2016, Radiology.
[17] Piet Claus,et al. Tissue Tracking Technology for Assessing Cardiac Mechanics: Principles, Normal Values, and Clinical Applications. , 2015, JACC. Cardiovascular imaging.
[18] William T. Clarke,et al. Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes , 2015, Diabetes.
[19] B. Gerber,et al. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T , 2015, Journal of Cardiovascular Magnetic Resonance.
[20] A. Voss,et al. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy. , 2015, European heart journal cardiovascular Imaging.
[21] Angelo Avogaro,et al. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. , 2015, JACC. Heart failure.
[22] A. Satoskar,et al. Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria , 2013, Molecular and Cellular Biochemistry.
[23] M. Robson,et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.
[24] James O. Mudd,et al. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. , 2012, Radiology.
[25] P. Kellman,et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.
[26] Jeroen J. Bax,et al. Association Between Diffuse Myocardial Fibrosis by Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping and Subclinical Myocardial Dysfunction in Diabetic Patients: A Pilot Study , 2012, Circulation. Cardiovascular imaging.
[27] P. Croisille,et al. Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] M. Hayward,et al. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.
[29] Jeroen J. Bax,et al. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. , 2009, The American journal of cardiology.
[30] S. Bansilal,et al. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. , 2008, The American journal of medicine.
[31] David M Higgins,et al. Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.
[32] W. Kannel,et al. Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.